China Pharma Holdings Return on Tangible Equity 2012-2026 | CPHI
Current and historical return on tangible equity values for China Pharma Holdings (CPHI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| China Pharma Holdings Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2026-03-31 | $0.00B | $0.00B | 533.33% |
| 2025-12-31 | $0.00B | -0 | 1600.00% |
| 2025-09-30 | $0.00B | 0 | -1600.00% |
| 2025-06-30 | $0.00B | $0.00B | -533.33% |
| 2025-03-31 | $0.00B | $0.00B | -266.67% |
| 2024-12-31 | $0.00B | $0.00B | -160.00% |
| 2024-09-30 | $0.00B | $0.00B | -123.08% |
| 2024-06-30 | $0.00B | $0.00B | -106.67% |
| 2024-03-31 | $0.00B | $0.00B | -106.67% |
| 2023-12-31 | $0.00B | $0.00B | -85.71% |
| 2023-09-30 | $0.00B | $0.00B | -100.00% |
| 2023-06-30 | $0.00B | $0.00B | -109.09% |
| 2023-03-31 | $0.00B | $0.00B | -100.00% |
| 2022-12-31 | $0.00B | $0.00B | -114.29% |
| 2022-09-30 | $0.00B | $0.01B | -88.89% |
| 2022-06-30 | $0.00B | $0.01B | -72.73% |
| 2022-03-31 | $0.00B | $0.01B | -66.67% |
| 2021-12-31 | $0.00B | $0.01B | -61.54% |
| 2021-09-30 | $0.00B | $0.01B | -57.14% |
| 2021-06-30 | $0.00B | $0.01B | -55.17% |
| 2021-03-31 | $0.00B | $0.01B | -38.71% |
| 2020-12-31 | $0.00B | $0.01B | -37.50% |
| 2020-09-30 | $-0.02B | $0.01B | -254.55% |
| 2020-06-30 | $-0.02B | $0.01B | -161.54% |
| 2020-03-31 | $-0.02B | $0.02B | -120.55% |
| 2019-12-31 | $-0.02B | $0.02B | -88.42% |
| 2019-09-30 | $-0.01B | $0.03B | -34.48% |
| 2019-06-30 | $-0.01B | $0.03B | -34.92% |
| 2019-03-31 | $-0.01B | $0.04B | -31.88% |
| 2018-12-31 | $-0.01B | $0.04B | -28.95% |
| 2018-09-30 | $-0.02B | $0.04B | -41.21% |
| 2018-06-30 | $-0.02B | $0.05B | -36.76% |
| 2018-03-31 | $-0.02B | $0.05B | -35.82% |
| 2017-12-31 | $-0.02B | $0.05B | -35.35% |
| 2017-09-30 | $-0.01B | $0.06B | -13.91% |
| 2017-06-30 | $-0.01B | $0.06B | -13.50% |
| 2017-03-31 | $-0.01B | $0.06B | -13.01% |
| 2016-12-31 | $-0.01B | $0.07B | -13.90% |
| 2016-09-30 | $-0.02B | $0.07B | -30.77% |
| 2016-06-30 | $-0.02B | $0.07B | -22.15% |
| 2016-03-31 | $-0.01B | $0.08B | -16.40% |
| 2015-12-31 | $-0.02B | $0.08B | -18.02% |
| 2015-09-30 | $-0.02B | $0.09B | -25.00% |
| 2015-06-30 | $-0.03B | $0.10B | -32.21% |
| 2015-03-31 | $-0.04B | $0.10B | -40.00% |
| 2014-12-31 | $-0.04B | $0.11B | -34.59% |
| 2014-09-30 | $-0.03B | $0.12B | -22.00% |
| 2014-06-30 | $-0.02B | $0.13B | -17.73% |
| 2014-03-31 | $-0.02B | $0.14B | -13.28% |
| 2013-12-31 | $-0.02B | $0.14B | -13.62% |
| 2013-09-30 | $-0.01B | $0.14B | -6.98% |
| 2013-06-30 | $-0.01B | $0.15B | -4.84% |
| 2013-03-31 | $0.00B | $0.15B | -0.69% |
| 2012-12-31 | $0.01B | $0.15B | 3.44% |
| 2012-09-30 | $0.01B | $0.14B | 6.97% |
| 2012-06-30 | $0.01B | $0.14B | 9.98% |
| 2012-03-31 | $0.02B | $0.13B | 13.18% |
| 2011-12-31 | $0.02B | $0.12B | 16.24% |
| 2011-09-30 | $0.02B | $0.11B | 19.86% |
| 2011-06-30 | $0.02B | $0.10B | 23.41% |
| 2011-03-31 | $0.02B | $0.09B | 25.74% |
| 2010-12-31 | $0.02B | $0.09B | 27.12% |
| 2010-09-30 | $0.02B | $0.08B | 25.89% |
| 2010-06-30 | $0.02B | $0.07B | 28.47% |
| 2010-03-31 | $0.02B | $0.07B | 26.67% |
| 2009-12-31 | $0.02B | $0.07B | 25.99% |
| 2009-09-30 | $0.02B | $0.07B | 29.41% |
| 2009-06-30 | $0.02B | $0.07B | 25.76% |
| 2009-03-31 | $0.02B | $0.06B | 26.98% |
| 2008-12-31 | $0.02B | $0.06B | 29.96% |
| 2008-09-30 | $0.02B | $0.05B | 31.84% |
| 2008-06-30 | $0.02B | $0.04B | 34.88% |
| 2008-03-31 | $0.01B | $0.04B | 38.62% |
| 2007-12-31 | $0.01B | $0.03B | 37.21% |
| 2007-09-30 | $0.01B | $0.03B | 39.29% |
| 2007-06-30 | $0.01B | $0.02B | 41.67% |
| 2007-03-31 | $0.01B | $0.02B | 45.00% |
| 2006-12-31 | $0.01B | $0.02B | 54.55% |
| 2006-09-30 | $0.01B | $0.01B | 63.16% |
| 2006-06-30 | $0.01B | $0.01B | 71.11% |
| 2006-03-31 | $0.01B | $0.01B | 80.00% |
| 2005-12-31 | $0.00B | $0.00B | 94.12% |
| 2005-09-30 | $0.00B | $0.00B | 80.00% |
| 2005-06-30 | $0.00B | 0 | 0.00% |
| 2004-12-31 | $0.00B | 0 | 0.00% |
| 2004-09-30 | $0.00B | 0 | 0.00% |
| 2003-12-31 | $0.00B | -0 | 0.00% |
| 2003-09-30 | $0.00B | $0.00B | 0.00% |
| 2002-12-31 | $0.00B | $0.00B | 0.00% |
| 2002-09-30 | $0.00B | -0 | 0.00% |
| 2002-03-31 | $0.00B | 0 | 0.00% |
| 2001-12-31 | $0.00B | 0 | 0.00% |
| 2001-09-30 | $0.00B | 0 | 0.00% |
| 2001-06-30 | $0.00B | 0 | 0.00% |
| 2001-03-31 | $0.00B | 0 | 0.00% |
| 2000-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.026B | $0.004B |
| CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |